Prediction Tools for Psychiatric Adverse Effects After Levetiracetam Prescription

Colin B. Josephson; Jordan D. T. Engbers; Nathalie Jetté; Scott Burton Patten; Shaily Singh; Tolulope T. Sajobi; Deborah A. Marshall; Yahya Aghakhani; Paolo Federico; Aaron Mackie; Sophie Macrodimitris; Brienne McLane; Neelan Pillay; Ruby Sharma; Samuel Wiebe

doi:10.1001/jamaneurol.2018.4561

Abstract

1 min read

This study derived 2 simple models that predict the risk of a psychiatric adverse effect from levetiracetam. These algorithms can be used to guide prescription in clinical practice.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2022

Clinical use, safety and effectiveness of novel high cost anticancer therapies after marketing approval: a record linkage study

Eva Negri, Marta Rossi, Martina Bonifazi, Matteo Franchi, Greta Carioli, Carlo Zocchetti, Giovanni Corrao, Carlo La Vecchia

Article2019

Opioid Prescription Patterns and Risk Factors Associated With Opioid Use in the Netherlands

Ajda Bedene, Willem M. Lijfering, Marieke Niesters, Monique van Velzen, Frits R. Rosendaal, Marcel L. Bouvy, Albert Dahan, E Dörp

JAMA Network Open

Article2021

Predicting Serum Levels of Lithium-Treated Patients: A Supervised Machine Learning Approach

Chih‐Wei Hsu, Shang‐Ying Tsai, Liang‐Jen Wang, Chih‐Sung Liang, André F. Carvalho, Marco Solmi, Eduard Vieta, Pao‐Yen Lin, Chien-An Hu, Hung‐Yu Kao

Article2022

Psychiatric diagnosis and treatment in the 21st century: paradigm shifts versus incremental integration

Dan Joseph Stein, Steven Shoptaw, Daniel Vigo, Crick Lund, Pim Cuijpers, Jason Bantjes, Norman Sartorius, Mario Maj

Article2022

Helicobacter pylori (H. pylori) risk factor analysis and prevalence prediction: a machine learning-based approach

Van Quan Tran, Tazmilur Saad, Mehret Tesfaye, Sosina Walelign, Moges Wordofa, Dessie Abera, Kassu Desta, Aster Tsegaye, Ahmet Ay, Bineyam Taye